AAAAAA
Results:
1-18
|
Results: 18
Authors:
Hiesse, C
Busson, M
Buisson, C
Farahmand, H
Bierling, P
Benbunan, M
Bedrossian, J
Aubert, P
Glotz, D
Loirat, C
Rondeau, E
Viron, B
Bleux, H
Lang, P
Citation: C. Hiesse et al., Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation, KIDNEY INT, 60(1), 2001, pp. 341-349
Authors:
Charpentier, B
Hiesse, C
Durrbach, A
Ammor, M
Von Ey, F
Kechrid, C
Kriaa, F
Citation: B. Charpentier et al., Overview of clinical trials with new agents, TRANSPLAN P, 33(3), 2001, pp. 2201-2203
Authors:
Ammor, M
Creput, C
Durrbach, A
Samuel, D
Von Ey, F
Hiesse, C
Droupy, S
Kriaa, F
Kreis, H
Benoit, G
Blanchet, P
Bismuth, H
Charpentier, B
Citation: M. Ammor et al., Mortality and long term outcome of combined liver and kidney transplantations, TRANSPLAN P, 33(1-2), 2001, pp. 1179-1180
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
Authors:
Mourad, G
Garrigue, V
Squifflet, JP
Besse, T
Berthoux, F
Alamartine, E
Durand, D
Rostaing, L
Lang, P
Baron, C
Glotz, D
Antoine, C
Vialtel, P
Romanet, T
Lebranchu, Y
Al Najjar, A
Hiesse, C
Potaux, L
Merville, P
Touraine, JL
Lefrancois, N
Kessler, M
Renoult, E
Pouteil-Noble, C
Cahen, R
Legendre, C
Bedrossian, J
Le Pogamp, P
Rivalan, J
Olmer, M
Purgus, R
Mignon, F
Viron, B
Charpentier, B
Citation: G. Mourad et al., Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression, TRANSPLANT, 72(6), 2001, pp. 1050-1055
Authors:
Boubenider, S
Vincent, I
Lambotte, O
Roy, S
Hiesse, C
Taburet, AM
Charpentier, B
Citation: S. Boubenider et al., Interaction between theophylline and tacrolimus in a renal transplant patient, NEPH DIAL T, 15(7), 2000, pp. 1066-1068
Authors:
Benoit, G
Paradis, V
Droupy, S
Amor, M
Lang, PH
Antoine, C
Bedrossian, J
Kessler, M
Rondeau, E
Peraldi, MN
Hourmant, M
Eschwege, P
Joseph, L
Robert, J
Hiesse, C
Charpentier, B
Bedossa, P
Citation: G. Benoit et al., What is the value of procurement biopsy lipid peroxidation lesions in the assessment of kidney graft function?, TRANSPLAN P, 32(8), 2000, pp. 2744-2744
Authors:
Khoury, N
Kriaa, F
Hiesse, C
Von Ey, F
Durbach, A
Ammor, M
Hafi, A
Djeffal, R
Boubenider, S
Droupy, S
Hammoudi, Y
Eschwege, P
Benoit, G
Charpentier, B
Citation: N. Khoury et al., Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression, TRANSPLAN P, 32(8), 2000, pp. 2763-2764
Authors:
Djeffal, R
Hiesse, C
Kriaa, F
Hafi, A
Boubenider, S
Ammor, M
Durrbach, A
Von Ey, F
Droupy, S
Hammoudi, Y
Eschwege, P
Benoit, G
Charpentier, B
Citation: R. Djeffal et al., Treatment with mycophenolate mofetil in long-term renal transplant recipients: Single-center experience in 28 patients, TRANSPLAN P, 32(8), 2000, pp. 2765-2766
Authors:
Droupy, S
Blanchet, P
Eschwege, P
Hammoudi, Y
Joseph, L
Robert, J
Hiesse, C
Charpentier, B
Devictor, D
Huault, G
Benoit, G
Citation: S. Droupy et al., Functional results in kidneys procured from pediatric cadavers, TRANSPLAN P, 32(8), 2000, pp. 2767-2768
Authors:
Blanchet, P
Hammoudi, Y
Eschwege, P
Droupy, S
Bensadoun, H
Hiesse, C
Charpentier, B
Benoit, G
Citation: P. Blanchet et al., Urinary complications after kidney transplantation can be reduced, TRANSPLAN P, 32(8), 2000, pp. 2769-2769
Authors:
Charpentier, B
Hiesse, C
Marchand, S
Boubenider, S
Ammor, M
Kechrid, C
Benoit, G
Durrbach, A
Citation: B. Charpentier et al., Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies, TRANSPLAN P, 32(2), 2000, pp. 367-367
Authors:
Lahlou, A
Lang, P
Charpentier, B
Barrou, B
Glotz, D
Baron, C
Hiesse, C
Kreis, H
Legendre, C
Bedrossian, J
Mougenot, B
Sraer, JD
Rondeau, E
Citation: A. Lahlou et al., Hemolytic uremic syndrome - Recurrence after renal transplantation, MEDICINE, 79(2), 2000, pp. 90-102
Authors:
Boubenider, S
Hiesse, C
Marchand, S
Hafi, A
Kriaa, F
Charpentier, B
Citation: S. Boubenider et al., Post-transplantation polyomavirus infections, J NEPHROL, 12(1), 1999, pp. 24-29
Authors:
Gross, M
Hiesse, C
Kriaa, F
Goldwasser, F
Citation: M. Gross et al., Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine, ANTI-CANC D, 10(6), 1999, pp. 533-536
Authors:
Marchand, S
Tchernia, G
Hiesse, C
Tertian, G
Cartron, J
Kriaa, F
Boubenider, S
Goupy, C
Lecointe, D
Charpentier, B
Citation: S. Marchand et al., Human parvovirus B19 infection in organ transplant recipients, CLIN TRANSP, 13(1), 1999, pp. 17-24
Authors:
Charpentier, B
Hiesse, C
Marchand, S
Boubenider, S
Durrbach, A
Kriaa, F
Citation: B. Charpentier et al., De novo and recurrent diseases: Recurrent glomerulopathies, TRANSPLAN P, 31(1-2), 1999, pp. 264-266
Authors:
Hiesse, C
Kriaa, F
Eschwege, P
Boubenider, S
Marchand, S
Benoit, G
Charpentier, B
Citation: C. Hiesse et al., Long-term results and risk factors of quadruple immunosuppression in renaltransplantation, TRANSPLAN P, 31(1-2), 1999, pp. 1111-1112
Authors:
Farge, D
Lebbe, C
Marjanovic, Z
Tuppin, P
Mouquet, C
Peraldi, HN
Lang, P
Hiesse, C
Antoine, C
Legendre, C
Bedrossian, J
Gagnadoux, HF
Loirat, C
Pellet, C
Sheldon, J
Golmard, JL
Agbalika, F
Schulz, TF
Citation: D. Farge et al., Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidneytransplant recipients, TRANSPLANT, 67(9), 1999, pp. 1236-1242
Risultati:
1-18
|